Projecten per jaar
Persoonlijk profiel
Expertise
Vingerafdruk
- 1 Soortgelijke profielen
Samenwerkingen en hoofdonderzoeksgebieden uit de afgelopen vijf jaar
Projecten
- 1 Actief
-
VLAIM5: Innovatiemandaat Spin-off finaliteit: EVOZymes Development Platform
Neuckermans, J., De Kock, J. & Vanhaecke, T.
1/08/23 → 31/07/25
Project: Toegepast
-
Development of a robust high-throughput screenings system for the evaluation of tyrosine ammonia lyases in the context of inborn errors of tyrosine metabolism
Nulmans, I., Laga, C. A., Salvi, N. S., Desmet, L., Lequeue, S., Neuckermans, J. & De Kock, J., 19 sep 2023.Onderzoeksoutput: Poster
-
Hereditary Tyrosinemia Type 1 Mice under Continuous Nitisinone Treatment Display Remnants of an Uncorrected Liver Disease Phenotype
Neuckermans, J., Lequeue, S., Claes, P., Heymans, A., Hughes, J. H., Colemonts-Vroninks, H., Marcélis, L., Casimir, G., Goyens, P., Martens, G. A., Gallagher, J. A., Vanhaecke, T., Bou-Gharios, G. & De Kock, J., 11 mrt 2023, In: Genes. 14, 3, 15 blz., 693.Onderzoeksoutput: Article › peer review
Open Access -
A robust bacterial high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of alkaptonuria
Lequeue, S., Neuckermans, J., Nulmans, I., Schwaneberg, U., Vanhaecke, T. & De Kock, J., 14 nov 2022, In: Scientific Reports. 12, 1, blz. 1-15 15 blz., 19452.Onderzoeksoutput: Article › peer review
Open AccessBestand1 Citaat (Scopus)10 Downloads (Pure) -
Development of a robust high-throughput screening system for the evaluation of human homogentisate 1,2-dioxygenase missense variants in the context of rare disease alkaptonuria
Lequeue, S., Neuckermans, J., Vanhaecke, T. & De Kock, J., 2022.Onderzoeksoutput: Poster
-
Development of a robust high-throughput screening system to evaluate single nucleotide polymorphisms of human homogentisate 1,2-dioxygenase in the context of rare disease alkaptonuria
Lequeue, S., Neuckermans, J., Vanhaecke, T. & De Kock, J., 2022.Onderzoeksoutput: Poster
Open Access
Activiteiten
-
World Orphan Drugs Rare Disease Day
Jessie Neuckermans (Participant)
2 mrt 2021Activiteit: Participation in conference
-
-
World Advanced Therapies & Regenerative Medicine 2021
Jessie Neuckermans (Participant)
1 apr 2021 → 3 apr 2021Activiteit: Participation in conference
-
World Advanced Therapies and Regenerative medicine 2020
Jessie Neuckermans (Participant)
7 sep 2020 → 9 sep 2020Activiteit: Participation in conference
-
EASL 2020
Jessie Neuckermans (Participant)
27 aug 2020 → 29 aug 2020Activiteit: Participation in conference
Scriptie
-
Bepaling van het optimale mRNA elektroporatieprotocol voor humane huidafgeleide stamcellen.
Auteur: Neuckermans, J. & Vanhaecke, T., 2016Scriptie/Masterproef: Master's Thesis
-
Establishment of the optimal mRNA electroporation protocol for human skin-derived stem cells
Auteur: Neuckermans, J. & De Kock, J., 2016Begeleider: De Kock, J. (Promotor)
Scriptie/Masterproef: Master's Thesis
-
Evaluatie van de efficiëntie van CRE mRNA-geïnduceerde recombinase in humane huidafgeleide mesenchymale stamcellen.
Auteur: Rombaut, M., Vanhaecke, T., De Kock, J. & Neuckermans, J., 2018Begeleider: Vanhaecke, T. (Promotor)
Scriptie/Masterproef: Master's Thesis